1. Home
  2. ESI vs BMRN Comparison

ESI vs BMRN Comparison

Compare ESI & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Element Solutions Inc.

ESI

Element Solutions Inc.

SELL

Current Price

$42.52

Market Cap

9.5B

Sector

Industrials

ML Signal

SELL

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$54.03

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESI
BMRN
Founded
1922
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
10.5B
IPO Year
2014
1999

Fundamental Metrics

Financial Performance
Metric
ESI
BMRN
Price
$42.52
$54.03
Analyst Decision
Strong Buy
Buy
Analyst Count
9
18
Target Price
$35.56
$88.22
AVG Volume (30 Days)
2.6M
1.5M
Earning Date
04-28-2026
05-04-2026
Dividend Yield
0.83%
N/A
EPS Growth
N/A
N/A
EPS
0.79
1.80
Revenue
$2,551,200,000.00
$1,313,646,000.00
Revenue This Year
$21.24
$15.02
Revenue Next Year
$7.34
$12.23
P/E Ratio
$49.15
$29.59
Revenue Growth
3.84
17.62
52 Week Low
$20.43
$50.76
52 Week High
$41.20
$66.28

Technical Indicators

Market Signals
Indicator
ESI
BMRN
Relative Strength Index (RSI) 70.75 44.61
Support Level $24.31 $53.45
Resistance Level N/A $56.21
Average True Range (ATR) 1.49 1.34
MACD 0.26 -0.01
Stochastic Oscillator 86.07 45.31

Price Performance

Historical Comparison
ESI
BMRN

About ESI Element Solutions Inc.

Element Solutions Inc is a specialty chemicals company whose businesses supply a broad range of solutions that enhance the performance of products people use every day. The company's reportable segments are Electronics and Industrial & Specialty. The Electronics segment, which generates maximum revenue, researches, formulates, and sells specialty chemicals and process technologies for all types of electronics hardware, from complex printed circuit board designs to semiconductor packaging. This segment's wet chemicals for metallization, surface treatments, and solderable finishes form the physical circuitry pathways, and its assembly materials, such as solder, pastes, fluxes, and adhesives, join those pathways together.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: